
Infosys shares rose 10% following strong Q3 results, with Nuvama increasing the target price to Rs 1,900. The company reported two consecutive quarters of solid deal wins and growth, particularly in Healthcare and BFSI sectors, while Manufacturing and Retail CPG faced challenges. Adjusted EBIT margin improved to 21.2%, despite one-time labor code-related expenses, indicating positive growth prospects for upcoming quarters.
Select a news story to see related coverage from other media outlets.